BA Tech — SHANGHAI BA TECHNOLOGY CO., LTD.
CORE CAPABILITIES

Core Capabilities

End-to-end industrial collaboration capabilities connecting frontier therapeutic technologies with international manufacturing and market execution.

WHAT WE DO

Core Business Pillars

Covering the full operational chain from asset licensing and process automation to local equipment deployment.

01

Cross-Border Biopharma & Synthetic Biology Licensing

Targeted sourcing, asset evaluation, and bidirectional In/Out-Licensing of clinical biopharma pipelines and synthetic biology technologies.

Key Scopes & Deliverables
•Technical evaluation and cross-border licensing of clinical-stage AAV, CAR-T, and related CGT assets
•In/Out-Licensing for high-yield strain engineering and enzymatic biomanufacturing technologies
•Cross-regional regulatory alignment, clinical mutual-recognition pathways, and BD execution
•Cross-jurisdiction transaction structuring and intellectual property compliance support
02

CGT Process Automation & Equipment Delivery

Collaborating with specialized domestic engineering partners to deliver cGMP-compliant, automated production systems ready for process validation.

Key Scopes & Deliverables
•All-in-One automated cell therapy manufacturing systems and modular processing platforms
•Microfluidic cell encapsulation and 3D microsphere/microcarrier process development
•Closed, automated 3D cell expansion and perfusion culture system integration
•Automated low-shear cell harvesting, washing, and closed aseptic transfer units
•cGMP-compliant aseptic filling and final formulation workstations
03

Industrial Equipment Supply & Local Deployment

Leveraging China's advanced bioprocess equipment network for equipment selection, commissioning, training, and ongoing service.

Key Scopes & Deliverables
•High-precision sterile tube welders and RF heat sealers for blood centers and biomanufacturing
•Closed aseptic fluid transfer, single-use flow paths, and automated aseptic connection systems
•1,000L pilot-scale industrial bioreactor scale-up engineering and full SOP validation
•Supplier cGMP audits, FAT/SAT acceptance, localized SOP handover, and steady-state consumable supply
OUR STRENGTHS

Core Advantages

Driven by technical depth, multilingual cross-border execution, and vetted regional networks.

01

International Academic & Industry Pedigree

Leadership trained at Tsinghua University and the University of Hong Kong, with multinational operating experience across the United States, Japan, and Canada.

02

Multilingual Commercial Execution

Fluent business and technical execution across Chinese, English, and Japanese, supported by deep Russian-speaking networks and Turkish market experience.

03

Technical & Commercial Integration

Specialized in cell & gene therapy (CGT), automated bioprocessing, NGS workflows, GMP facility integration, and cross-border drug In/Out-Licensing.

04

Regional Market & Regulatory Reach

Deeply active across Russia, Central Asia, and the Middle East, while connecting directly with European and Asia-Pacific life science hubs.

Business Inquiries

Start a Cross-Border
Biopharma & Biotech Collaboration

Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.

Business Emailcontact@shbatech.com
LocationShanghai, China
Send Business Email